UK foot and mouth lab leaks again

A Surrey, UK, lab thought to be the linkurl:source;http://www.the-scientist.com/news/display/53474/ of a foot and mouth disease (FMD) outbreak in August again ran afoul of biosafety practices last week, when a leaking valve likely released live FMD virus into a contained drainage system. Merial, a company on the site that makes FMD vaccine, had been banned from using live virus after the August outbreak, but the government restored its license to work with FMD earlier this month when biosafety

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A Surrey, UK, lab thought to be the linkurl:source;http://www.the-scientist.com/news/display/53474/ of a foot and mouth disease (FMD) outbreak in August again ran afoul of biosafety practices last week, when a leaking valve likely released live FMD virus into a contained drainage system. Merial, a company on the site that makes FMD vaccine, had been banned from using live virus after the August outbreak, but the government restored its license to work with FMD earlier this month when biosafety measures were upgraded. The leak, which occurred on Monday (November 19), came to light when the workers noticed a shortfall in the amount of virus being recovered in the vaccine production process, according to a Department for Environment, Food and Rural Affairs (Defra) linkurl:report.;http://www.defra.gov.uk/corporate/ministers/statements/hb071122.htm Engineers called to inspect the system found that problem lay in a valve separating a line carrying live virus from a line carrying waste on its way to a chemical treatment facility. Merial reported the problem to Defra late Tuesday afternoon. Inspectors who visited the site Wednesday said they believe that no virus escaped into the environment. "The extensive layers of biosecurity that we require?effectively contained the virus in the closed, re-lined drainage system before deactivation in the chemical treatment facility," Defra's report states. But the incident raises the question of whether the facility is equipped to be handling live virus at all, according to UK linkurl:media;http://www.timesonline.co.uk/tol/news/uk/article2922474.ece reports. The company's license to work with both FMD and bluetongue virus have again been suspended.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies